Activer l’accessibilitéActiver l’accessibilité

Rapport d'activité de coopération des organisations de patients en 2020

En 2020, Takeda Suisse a collaboré avec les organisations de patients suivantes et leur a apporté un soutien financier:

 

Takeda Switzerland Patient Organisations disclosure 2020

 Publication date: 26th June 2021

 

PO name
Country
Types of the support or services provided
Description of the support or services
Monetary value of financial support and of invoiced costs
Non-monetary benefit for PO
Fees for services paid
Lung Cancer Europe (LUCE) CH - Switzerland Contracted Services Participation at Advisory Board     SFr. 9'383.56
Lung Cancer Europe (LUCE) CH - Switzerland Contracted Services Participation at Advisory Board     SFr. 3'926.80
Lung Cancer Europe (LUCE) CH - Switzerland Financial Support Support for annual meeting Sfr. 26'610.00    
Schweizerische Vereinigung Eosinophile
Ösophagitis		 CH - Switzerland Financial Support Grant for patient information event SFr. 2'000.00    
Verein Lymphome.ch CH - Switzerland Financial Support Grant for translation of patient materials SFr. 10'825.00    
Verein Lymphome.ch CH - Switzerland Financial Support Donation SFr. 2'500.00    
Verein Lunge Zürich CH - Switzerland Non-financial Support Sponsorship of annual activities SFr. 4'400.00    
Rheumaliga Schweiz CH - Switzerland Financial Support Support for disease awareness publication SFr. 10'000.00    
ProRaris CH - Switzerland Contracted Services Participation at Advisory Board     SFr. 1'350
Crohn Colitis Schweiz CH - Switzerland Financial Support Grant for annual activities SFr. 20'000.00    
Crohn Colitis Schweiz CH - Switzerland Financial Support Grant for activities related to IBD Day SFr. 20'000.00    
SHG-ASH CH - Switzerland Financial Support Support for disease awareness publication SFr. 6'000.00    
Myelom Patienten Schweiz CH - Switzerland Financial Support Donation SFr. 2'500.00    
Myelom Patienten Schweiz CH - Switzerland Financial Support Grant for website development SFr. 5'000.00    
GBS & CIDP Initiative Schweiz CH - Switzerland Financial Support Grant for patient information event SFr. 2'500.00    
Copyright 1995-2023 Takeda Pharmaceutical Company Limited. Tous droits réservés.